Profile
Athanasios Tsiatis currently works at ALX Oncology Holdings, Inc., as Senior Vice President-Clinical Development from 2021.
Dr. Tsiatis also formerly worked at Plexxikon, Inc., as Vice President-Clinical Development from 2020 to 2021.
Dr. Tsiatis received his undergraduate degree from New York University and doctorate degree from Vanderbilt University School of Medicine.
Athanasios Tsiatis active positions
| Companies | Position | Start |
|---|---|---|
| ALX ONCOLOGY HOLDINGS INC. | Chief Tech/Sci/R&D Officer | 2021-10-31 |
Former positions of Athanasios Tsiatis
| Companies | Position | End |
|---|---|---|
Plexxikon, Inc.
Plexxikon, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical and medical drug discovery and development services | Chief Tech/Sci/R&D Officer | 2021-10-31 |
Training of Athanasios Tsiatis
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Plexxikon, Inc.
Plexxikon, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical and medical drug discovery and development services | Commercial Services |
New York University
New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vanderbilt University School of Medicine
Vanderbilt University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ALX Oncology Holdings, Inc.
ALX Oncology Holdings, Inc. BiotechnologyHealth Technology Operates as clinical stage immuno-oncology company, which develops therapies for cancer | Health Technology |
- Stock Market
- Insiders
- Athanasios Tsiatis
















